Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem, 26446 [2019-11878]
Download as PDF
<![CDATA[
26446
Federal Register / Vol. 84, No. 109 / Thursday, June 6, 2019 / Notices
therefore has determined to exercise its
authority to extend the review period by
up to 90 days pursuant to 19 U.S.C.
1675(c)(5)(B).
Authority: This review is being
conducted under authority of title VII of
the Tariff Act of 1930; this notice is
published pursuant to section 207.62 of
the Commission’s rules.
By order of the Commission.
Issued: May 31, 2019.
Lisa Barton,
Secretary to the Commission.
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: American
Radiolabeled Chem
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before August 5, 2019.
DATES:
[FR Doc. 2019–11819 Filed 6–5–19; 8:45 am]
BILLING CODE 7020–02–P
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
ADDRESSES:
DEPARTMENT OF JUSTICE
In
accordance with 21 CFR 1301.33(a), this
is notice that on March 7, 2019,
American Radiolabeled Chem, 101 Arc
Drive, Saint Louis, Missouri 63146
applied to be registered as a bulk
manufacturer of the following basic
classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...........................................................................................................................................
Ibogaine ...........................................................................................................................................................................
Lysergic acid diethylamide ..............................................................................................................................................
Tetrahydrocannabinols ....................................................................................................................................................
Dimethyltryptamine ..........................................................................................................................................................
1-[1-(2-Thienyl)cyclohexyl]piperidine ...............................................................................................................................
Dihydromorphine .............................................................................................................................................................
Heroin ..............................................................................................................................................................................
Normorphine ....................................................................................................................................................................
Amphetamine ...................................................................................................................................................................
Methamphetamine ...........................................................................................................................................................
Amobarbital ......................................................................................................................................................................
Phencyclidine ...................................................................................................................................................................
Phenylacetone .................................................................................................................................................................
Cocaine ............................................................................................................................................................................
Codeine ...........................................................................................................................................................................
Dihydrocodeine ................................................................................................................................................................
Oxycodone .......................................................................................................................................................................
Hydromorphone ...............................................................................................................................................................
Ecgonine ..........................................................................................................................................................................
Hydrocodone ...................................................................................................................................................................
Meperidine .......................................................................................................................................................................
Metazocine ......................................................................................................................................................................
Methadone .......................................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ..............................................................................................................
Morphine ..........................................................................................................................................................................
Oripavine .........................................................................................................................................................................
Thebaine ..........................................................................................................................................................................
Oxymorphone ..................................................................................................................................................................
Phenazocine ....................................................................................................................................................................
Carfentanil .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
small quantities of the above-listed
controlled substances as radiolabeled
compounds for biochemical research.
Dated: May 24, 2019.
John J. Martin,
Assistant Administrator.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Shertech Laboratories,
LLC
khammond on DSKBBV9HB2PROD with NOTICES
[FR Doc. 2019–11878 Filed 6–5–19; 8:45 am]
ACTION:
BILLING CODE 4410–09–P
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before July 8, 2019. Such persons
may also file a written request for a
VerDate Sep<11>2014
16:11 Jun 05, 2019
Jkt 247001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
hearing on the application on or before
July 8, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
SUPPLEMENTARY INFORMATION:
Notice of application.
DATES:
2010
7260
7315
7370
7435
7470
9145
9200
9313
1100
1105
2125
7471
8501
9041
9050
9120
9143
9150
9180
9193
9230
9240
9250
9273
9300
9330
9333
9652
9715
9743
9801
Schedule
E:\FR\FM\06JNN1.SGM
06JNN1
]]>Agencies
[Federal Register Volume 84, Number 109 (Thursday, June 6, 2019)]
[Notices]
[Page 26446]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-11878]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: American
Radiolabeled Chem
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before August 5, 2019.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 7, 2019, American Radiolabeled Chem, 101 Arc
Drive, Saint Louis, Missouri 63146 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.......... 2010 I
Ibogaine........................... 7260 I
Lysergic acid diethylamide......... 7315 I
Tetrahydrocannabinols.............. 7370 I
Dimethyltryptamine................. 7435 I
1-[1-(2- 7470 I
Thienyl)cyclohexyl]piperidine.
Dihydromorphine.................... 9145 I
Heroin............................. 9200 I
Normorphine........................ 9313 I
Amphetamine........................ 1100 II
Methamphetamine.................... 1105 II
Amobarbital........................ 2125 II
Phencyclidine...................... 7471 II
Phenylacetone...................... 8501 II
Cocaine............................ 9041 II
Codeine............................ 9050 II
Dihydrocodeine..................... 9120 II
Oxycodone.......................... 9143 II
Hydromorphone...................... 9150 II
Ecgonine........................... 9180 II
Hydrocodone........................ 9193 II
Meperidine......................... 9230 II
Metazocine......................... 9240 II
Methadone.......................... 9250 II
Dextropropoxyphene, bulk (non- 9273 II
dosage forms).
Morphine........................... 9300 II
Oripavine.......................... 9330 II
Thebaine........................... 9333 II
Oxymorphone........................ 9652 II
Phenazocine........................ 9715 II
Carfentanil........................ 9743 II
Fentanyl........................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the above-
listed controlled substances as radiolabeled compounds for biochemical
research.
Dated: May 24, 2019.
John J. Martin,
Assistant Administrator.
[FR Doc. 2019-11878 Filed 6-5-19; 8:45 am]
BILLING CODE 4410-09-P
